By Benjamin Chiou
Date: Tuesday 15 Apr 2025
(Sharecast News) - American healthcare and consumer products giant Johnson & Johnson hiked its annual guidance after a strong start to the year, with the company beating estimates on both the top and bottom lines.
Johnson & Johnson agrees to pay £13bn for Switze... | 28-Apr-2011 | The Independent |
S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
J&J asks judge to dismiss kickback case | 08-Oct-2010 | Wall Street Journal |
Genzyme Again Rejects Sanofi’s Bid | 08-Oct-2010 | New York Times |
Johnson & Johnson buying vaccine maker Crucell | 07-Oct-2010 | USA Today |
Currency | US Dollars |
Share Price | $ 152.94 |
Change Today | $ 0.33 |
% Change | 0.22 % |
52 Week High | $167.70 |
52 Week Low | $142.06 |
Volume | 6,727,539 |
Shares Issued | 2,406.92m |
Market Cap | $368,115m |
Beta | 0.03 |
RiskGrade | 87 |
Strong Buy | 5 |
Buy | 5 |
Neutral | 14 |
Sell | 0 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
15:59 | 600 @ $152.94 |
15:59 | 100 @ $152.95 |
15:59 | 400 @ $152.95 |
15:59 | 500 @ $152.94 |
15:59 | 100 @ $152.94 |
You are here: research